10th Annual Houston Methodist Cancer Symposium

August 12, 2022

LIVE (In-Person) and LIVESTREAM (Virtual) attendance options are available. 

Presented by the Houston Methodist Dr. Mary and Ron Neal Cancer Center

This annual symposium, dedicated to the science and clinical care of solid and hematologic malignancies, brings together Houston Methodist scientists and physicians from a broad spectrum of fields, including basic, clinical and epidemiological research. A wide range of topics will be covered, from innovative translational science to clinical updates with strategies for implementation in current clinical practice. The program will provide education focused on improving patient care, research collaboration and leading medicine.

Click Here to View Brochure

ACCEPTING ABSTRACTS!

The Houston Methodist Cancer Center invites abstracts for poster presentation at the 10th Annual Houston Methodist Cancer Symposium.

Accepted abstracts will be presented as posters on Friday, August 12, 2022 during the Houston Methodist Cancer Symposium. The purpose of the poster session is to provide a forum for discussion of innovations in every aspect of cancer research and care, including but not limited to: Molecular and Cell Biology, Tumor Biology, Cancer Chemistry, Immunology.

The Review Committee will evaluate the scientific quality of the submitted abstracts on the basis of the following criteria: Clinical Research, Epidemiology and Prevention, Clinical Vignettes.

ABSTRACT SUBMISSIONS ARE NO LONGER BEING ACCEPTED

FEES

REGISTRATION TYPEFEE

Houston Methodist Employees

Free

External (Non-Houston Methodist) 

 

Physician (Private physician located within the Greater Houston Area)

$250

Physician (Private physician located outside the Greater Houston Area)

$125

Research Scientist

$40

Allied Health Care Professional

$40

Resident / Fellow / Student

$20

Target Audience

Physician scientists, practicing oncologists, advanced nurse practitioners and physician assistants, oncology nurses, residents, fellows, medical students, allied health personnel and clinical research associates will benefit from this course.

Learning Objectives

At the conclusion of this activity, the participant should be able to: 

  • Describe the role of genomics in multiple myeloma
  • Discuss new modalities of therapy in multiple myeloma
  • Discuss the importance of supportive care in patients with multiple myeloma
Course summary
Available credit: 
  • 6.75 AMA PRA Category 1 Credit

    Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Houston Methodist designates this Live activity for a maximum of 6.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 6.75 Attendance
  • 5.91 Nursing Contact Hours

    Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

    Houston Methodist will award 5.91 Nursing Continuing Professional Development contact hours for this activity. Participants must attend the activity in its entirety and complete the continuing education evaluation.

Course opens: 
05/09/2022
Course expires: 
10/31/2022
Event starts: 
08/12/2022 - 8:00am CDT
Event ends: 
08/12/2022 - 4:45pm CDT
TimePresentationSpeaker(s)
8:00 AMRegistration 
8:15 AMWelcome: Announcements and Introductions Jenny C. Chang, MD
8:30 AMRole of Genomics in Multiple MyelomaNikhil C. Munshi, MD
9:15 AMQuestion and Answer 
9:25 AMOverview of Advances in  Multiple MyelomaSiddhartha Ganguly, MD, FACP 
9:55 AMQuestion and Answer 
10:00 AMBreak and Exhibits
10:25 AMBasic and Translational Research Updates in Multiple MyelomaQing Yi, MD, PhD 
10:55 AMQuestion and Answer 
11:00 AMSupportive Care in MyelomaRebecca Lu, MSN, FNP-C
11:30 AMQuestion and Answer 
11:35 AMLUNCH KEYNOTE: Climate Change and CancerJoan H. Schiller, MD
12:35 PMLunch and Exhibits
1:00 PMSOLID TUMOR KEYNOTE: Overview of Cancer ChemopreventionMing You, MD, PhD
1:45 PMQuestion and Answer 
1:55 PMManagement of Prostate Cancer 2022 Eleni Efstathiou, MD, PhD
2:25 PMQuestion and Answer 
2:30 PMBreak and Exhibits
2:45 PMBreast Cancer Radiotherapy and QualityWaqar M. Haque, MD
3:15 PMQuestion and Answer 
3:20 PMBreak and Exhibits
3:40 PMAbstract Winner Discussions 
4:30 PMQuestion and Answer 
4:45 PMAdjournment
LIVE (in-person) and LIVESTREAM (virtual) attendance options are available.

LIVE (in-person attendance) will be held in the Houston Methodist Research Institute, 6670 Bertner Avenue, Houston, Texas 77030). 

LIVESTREAM information will be provided to registered learners. 

COURSE DIRECTORS
Eric H. Bernicker, MD
Diane Harkins Modesett Professor of Medical Oncology
Professor of Clinical Oncology, Academic Institute
Full Clinical Member, Research Institute
Dr. Mary and Ron Neal Cancer Center
Department of Medicine
Houston Methodist Hospital
Weill Cornell Medical College
Shilpan Shah, MD
Assistant Professor of Clinical Medicine in Oncology
Academic Institute
Houston Methodist
Weill Cornell Medical College
Adjunct Assistant Professor
Texas A&M University College of Medicine
 
KEYNOTE SPEAKERS
Rebecca Lu
Supervisor Advanced Practice Provider Myeloma Research
Department of Lymphoma/Myeloma, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center 
Nikhil C. Munshi, MD
Kraft Family Chair
Director Basic and Correlative Sciences Associate Director
Jerome Lipper Multiple Myeloma Center
Department of Medical Oncology
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Joan H. Schiller, MD
Founding member,"Oncologists United for Climate and Health (OUCH)"
Adjunct Professor, University of Virginia
Board Member, Lung Cancer Research Foundation
 
HOUSTON METHODIST FACULTY
Eleni Efstathiou, MD, PhD
Section Chief of Genitourinary Medical Oncology
Houston Methodist Oncology Partners
Waqar M. Haque, MD
Associate Professor of Clinical Radiation Oncology, Academic Institute
Associate Clinical Member, Research Institute
Houston Methodist
Weill Cornell Medical College
Siddhartha Ganguly, MD, FACP
Carol Cockrell Curran Distinguished Centennial Chief in Hematologic Oncology, Dr. Mary and Ron Neal Cancer Center
Professor of Clinical Oncology, Academic Institute
Full Clinical Member, Research Institute
Houston Methodist
Qing Yi, MD, PhD
Ralph O’Connor Centennial Chair, Dr. Mary and Ron Neal Cancer Center
Professor of Oncology, Academic Institute
Full Member, Research Institute
Director, Center for Translational Research in Hematological Malignancies
Associate Director, Cancer Center Basic Research Programs, Dr. Mary and Ron Neal Cancer Center
Houston Methodist
Weill Cornell Medical College
Ming You, MD, PhD
Director, Center for Cancer Prevention, Dr. Mary and Ron Neal Cancer Center
Houston Methodist

Available Credit

  • 6.75 AMA PRA Category 1 Credit

    Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Houston Methodist designates this Live activity for a maximum of 6.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 6.75 Attendance
  • 5.91 Nursing Contact Hours

    Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

    Houston Methodist will award 5.91 Nursing Continuing Professional Development contact hours for this activity. Participants must attend the activity in its entirety and complete the continuing education evaluation.

We gratefully acknowledge the following companies for participating as exhibitors for this activity:

 

 

AbbVie

 

Astellas Pharma

 

AstraZeneca

 

BeiGene

 

BTG Specialty Pharma

 

Caris Life Sciences

 

CTI Biopharma

 

Eisai

 

Eli Lilly and Company

 

Exact Sciences

 

Exelixis

 

Gilead

 

Incyte Corporation

 

Merck

 

Millennium Pharmaceuticals

 

Morphosys

 

Pfizer

 

Pharmacyclics (PCYC)

 

Regeneron

 

Rigel Pharmaceuticals

 

Sanofi-Genzyme

 

Taiho

 
 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$250.00Included
There are no more spaces available for this course.
$250.00Included
Please login or register to take this course.
Please login or register to take this course.

REGISTRATION INSTRUCTIONS

  • STEP 1 - Choose the activity format you would like to attend (LIVE or LIVESTREAM) by selecting the checkbox next to the activity and clicking the "Enroll" button. 
  • STEP 2 - Once enrolled, click the link of the activity format for which you enrolled (the Status should say "In progress") and then click the "Take Course" button to begin the activity.

FEES

REGISTRATION TYPEFEE

Houston Methodist Employees

Free

External (Non-Houston Methodist) 

 

Physician (Private physician located within the Greater Houston Area)

$250

Physician (Private physician located outside the Greater Houston Area)

$125

Research Scientist

$40

Allied Health Care Professional

$40

Resident / Fellow / Student

$20